Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminorex SCHEMBL6803173 | 0.87 | HDAC3 (0.41) | TSHRTAAR1SLC6A3RAB9AMEN1 | |
| SCHEMBL31158568 | 0.81 | TSHR (0.50) | TSHRSLC6A3MEN1CYP2C19KMT2A | |
| SCHEMBL34460861 | 0.81 | TSHR (0.50) | TSHRSLC6A3MEN1CYP2C19KMT2A | |
| Clominorex SCHEMBL121090 | 0.81 | TAAR1 (0.46) | TAAR1SLC6A3RAB9AATMSMN1; SMN2 | |
| SCHEMBL14301430 | 0.76 | TSHR (0.45) | TSHRALDH1A1HPGDATMSMN1; SMN2 | |
| SCHEMBL2399688 | 0.76 | TSHR (0.45) | TSHRALDH1A1HPGDATMSMN1; SMN2 | |
| SCHEMBL1548278 | 0.76 | ALDH1A1 (0.54) | TSHRKMT2AALDH1A1HPGDATM | |
| SCHEMBL21033513 | 0.73 | TSHR (0.47) | TSHRTAAR1SLC6A3RAB9AMEN1 | |
| SCHEMBL5395444 | 0.73 | TSHR (0.38) | TSHRSLC6A3MEN1CYP2C19KMT2A | |
| Hydrochloric Acid SCHEMBL30845839 | 0.72 | TSHR (0.45) | TSHRTAAR1SLC6A3MEN1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2353 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| WO-2023212244-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | claimed |
| EP-3891505-B1 | A METHOD FOR MEASURING A CONCENTRATION OF A BIOMARKER/ANALYTE IN BLOOD FROM MAMMALS | REDHOTDIAGNOSTICS AB (SE) | 2022-11-30 | — | — | EP | claimed |
| US-20220187304-A1 | A Method for Measuring a Concentration of a Biomarker-Analyte In Blood from Mammals | REDHOT DIAGNOSTICS AB (SE) | 2022-06-16 | — | — | US | claimed |
| EP-3891505-A1 | A METHOD FOR MEASURING A CONCENTRATION OF A BIOMARKER/ANALYTE IN BLOOD FROM MAMMALS | REDHOTDIAGNOSTICS AB (SE) | 2021-10-13 | — | — | EP | claimed |
| WO-2020156849-A1 | A METHOD FOR MEASURING A CONCENTRATION OF A BIOMARKER/ANALYTE IN BLOOD FROM MAMMALS. | REDHOTDIAGNOSTICS AB (SE) | 2020-08-06 | — | — | WO | claimed |
| EP-3687576-A1 | USE OF CANNABIDIOL IN COMBINATION WITH 5-HT2B RECEPTOR AGONISTS OR AMPHETAMINS IN THE TREATMENT OF EPILEPSY | GW Research Limited (GB) | 2020-08-05 | — | — | EP | claimed |
| US-20200237683-A1 | USE OF CANNABIDIOL IN COMBINATION WITH 5-HT2B RECEPTOR AGONISTS OR AMPHETAMINS IN THE TREATMENT OF EPILEPSY | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2020-07-30 | — | — | US | claimed |
| US-20200060997-A1 | TARR Receptor Agonists for Sexual Dysfunction | JOHN MCCOY | 2020-02-27 | — | — | US | claimed |
| WO-2019064031-A1 | USE OF CANNABIDIOL IN COMBINATION WITH 5-HT2B RECEPTOR AGONISTS OR AMPHETAMINS IN THE TREATMENT OF EPILEPSY | GW Research Limited (GB) | 2019-04-04 | — | — | WO | claimed |
| EP-0977572-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING EATING DISORDERS | MERCK SHARP & DOHME LTD. (GB) | 2000-02-09 | — | — | EP | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| WO-1998047513-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING EATING DISORDERS | MERCK SHARP & DOHME LIMITED (GB) | 1998-10-29 | — | — | WO | claimed |
| US-5684018-A | Acyloxyisopropyl carbamates as prodrugs for amine drugs | MERCK & CO., INC. (US) | 1997-11-04 | — | — | US | claimed |
| EP-0724450-A1 | COMPOSITION FOR WEIGHT REDUCTION CONTAINING EPHEDRINE AND A MINERAL SALT OR CHELATE | Keown, Wendy J. (US) | 1996-08-07 | — | — | EP | claimed |
| US-5543405-A | MIXTURE OF EPHEDRINE AND CHROMIUM PICOLINATE | KEOWN WENDY J (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996018605-A1 | ACYLOXYISOPROPYL CARBAMATES AS PRODRUGS FOR AMINE DRUGS | MERCK & CO., INC. (US) | 1996-06-20 | — | — | WO | claimed |
| WO-1995011034-A1 | COMPOSITION FOR WEIGHT REDUCTION CONTAINING EPHEDRINE AND A MINERAL SALT OR CHELATE | KEOWN WENDY J (US) | 1995-04-27 | — | — | WO | claimed |
| US-5096712-A | METHOD FOR ENHANCING PERFORMANCE SO AS TO IMPROVE VIGOR AND DECREASE FATIGUE, CONFUSION, TENSION, AND ANXIETY | INTERNEURON PHARMACEUTICALS, INC. (US) | 1992-03-17 | — | — | US | claimed |
| US-5019594-A | Method for decreasing appetite | INTERNEURON PHARMACEUTICALS, INC. (US) | 1991-05-28 | — | — | US | claimed |